All members of participating institutions are encouraged to apply for the Enduring Hearts-PHTS Investigator Award. One project will be selected per PHTS proposal cycle (2 projects funded per year).
Terms of Award:
- For the primary investigator, $1,000 – $1,500 for travel to Birmingham, Alabama to meet with the Data Coordinating Center statisticians, to develop a statistical analysis plan for the approved project and to review the data at the study’s conclusion
- $1,500 to support the investigator’s attendance to either the ISHLT or AHA meetings provided that the investigator has an abstract accepted for oral or poster presentation
- Statistical Support provided by the PHTS DCC
Funding decisions will be based on scientific merit and alignment with the areas of scientific interest relevant to improving heart transplant recipient longevity as follows:
- Accurate, early identification of the onset of cellular and antibody-mediated rejection and cardiac allograft vasculopathy (CAV)
- Develop better non-invasive methods to accurately detect early heart rejection
- Develop evidence-based standardization of post-transplant protocols
- Development of innovative technologies or applications thereof to improve the care of transplant patients and thereby impact outcomes
- Develop novel and effective immunotherapies, identify of novel targets for immunosuppression, reduce the side effects of immunosuppressive agents as well as better monitoring and measurement of the level of immunosuppression
- Develop effective strategies to improve medication compliance, especially in adolescent patients and young adults
- Develop improved organ utilization, matching strategies and other innovations that would allow better organ matching, preservation, utilization and allocation.
Additional weight will be given to research that has a high likelihood of being translated into clinical practice within five years.
Previous Award Winners
Carmel Bogle, MD
Boston Children’s Hospital
Abstract: Obesity Leads to Increased Mortality in Pediatric Heart Transplant Recipients – A Pediatric Heart Transplant Society Study (ISHLT 2020)
Bethany Wisotzkey, MD
Phoenix Children’s Hospital
Abstract: Risk Factors for One-Year Mortality and Allograft Loss in Pediatric Heart Transplant Patients Using Machine Learning: Analysis of the PHTS Database (AHA 2020)
Laura D’Addese, MD
Joe DiMaggio Children’s Hospital
Abstract: Aspirin use and the development of cardiac allograft vasculopathy in pediatric heart transplant recipients (ISHLT 2021)